Cardinal Health Q2 EPS Surpasses Estimates by 10.5%, Guidance Rises to $10.15–$10.35
Cardinal Health reported non-GAAP Q2 EPS of $2.63, beating the $2.31 consensus by $0.32, with revenue rising 19% to $65.63 billion. The company raised fiscal 2026 non-GAAP EPS guidance to $10.15–$10.35 and saw segment profits increase 29%–106% across its Pharmaceutical and Medical Products divisions.
1. Strong Quarterly Earnings Beat Expectations
Cardinal Health reported non-GAAP earnings of $2.63 per share for the fiscal second quarter, surpassing consensus estimates by $0.32. Revenue rose 18.8% year-over-year to $65.63 billion, topping the $64.88 billion consensus forecast. The company generated non-GAAP operating earnings of $877 million, a 38% increase from the prior year, while GAAP operating earnings climbed 29% to $707 million. Despite a negative return on equity of 84.37%, Cardinal Health achieved a net margin of 0.68% and swung operating cash flow to a $686 million inflow from a $396 million outflow a year earlier. Management raised full-year non-GAAP EPS guidance to a range of $10.15–$10.35, reflecting robust segment profit growth and improved leverage ratios.
2. Analyst Ratings Strengthen and Price Targets Increase
Seventeen research reports have been issued in the past quarter: Weiss Ratings reiterated a Buy, Wall Street Zen upgraded to Strong-Buy, Argus lifted its price objective from $211 to $232, Mizuho set a $222 target, and Deutsche Bank moved its target from $195 to $208 while assigning a Hold. Overall, fourteen analysts rate the shares as Buy and one as Hold, yielding a consensus Moderate Buy with an average target of $233.29. Upgrades have been propelled by Cardinal Health’s double-digit profit expansion across its Pharmaceutical & Specialty Solutions and Global Medical Products segments, as well as its strategic acquisitions in specialty care and home-delivery solutions.
3. Significant Institutional Investor Activity Highlights Confidence
Institutional ownership stands at 87.17%, with several large funds adjusting positions in the latest quarter. Strategy Asset Managers initiated a stake valued at approximately $775,000. Mirae Asset Global Investments increased its holdings by 15.3% to 37,833 shares (worth $5.94 million). Atle Fund Management added 3,500 shares for a 13.1% boost to 30,297 shares ($4.76 million), and the National Pension Service expanded by 33,673 shares (7.2%) to a total 500,340 shares ($78.53 million). Baird Financial Group more than doubled its position, acquiring 51,416 additional shares for a total 99,393 shares ($16.70 million). These movements underscore institutional confidence in the company’s growth trajectory and capital allocation strategies.